Organization
Byron Lam
1 clinical trial
Clinical trial
An Open-label Dose Escalation Study of an Adeno-associated Virus Vector (scAAV2-P1ND4v2) for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation in Mitochondrial DNAStatus: Active (not recruiting), Estimated PCD: 2023-03-31